HNRNPA3 — Heterogeneous Nuclear Ribonucleoprotein A3
Overview
HNRNPA3 (Heterogeneous Nuclear Ribonucleoprotein A3) is a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) family that plays critical roles in RNA processing, including splicing, stability, transport, and localization. HNRNPA3 has garnered significant attention in [neurodegenerative disease](/diseases/neurodegeneration) research due to its involvement in [amyotrophic lateral sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis) and [frontotemporal dementia (FTD)](/diseases/frontotemporal-dementia), particularly in the context of [C9orf72 hexanucleotide repeat expansions](/genes/c9orf72). The protein localizes to stress granules and RNA granules, making it a key player in RNA homeostasis mechanisms that are disrupted in several neurodegenerative conditions.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">HNRNPA3</th></tr>
<tr><td><b>Gene Symbol</b></td><td>HNRNPA3</td></tr>
<tr><td><b>Full Name</b></td><td>Heterogeneous Nuclear Ribonucleoprotein A3</td></tr>
<tr><td><b>Aliases</b></td><td>HNRPA3, H3, FUBP2</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>10q12</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>10136</td></tr>
<tr><td><b>OMIM ID</b></td><td>605017</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000169020</td></tr>
<tr><td><b>UniProt ID</b></td><td>P51991</td></tr>
<tr><td><b>Protein Length</b></td><td>378 amino acids</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Normal Function
Protein Structure
HNRNPA3 belongs to the hnRNP A/B family, characterized by:
RNA recognition motifs (RRMs): Two RRMs (RRM1 and RRM2) for RNA binding
Glycine-rich domain: Involved in protein-protein interactions
Nuclear localization signals (NLS): Directs nuclear import
Nuclear export signals (NES): Enables cytoplasmic shuttlingRNA Binding Specificity
HNRNPA3 has distinct RNA binding properties:
- GU-rich sequences: Binds specifically to GU-rich RNA motifs
- Pre-mRNA interactions: Associates with splicing machinery
- mRNA trafficking: Participates in mRNA localization
Cellular Functions
HNRNPA3 participates in multiple RNA-related processes:
| Function | Description |
|----------|-------------|
| Alternative splicing | Regulates exon inclusion/exclusion |
| mRNA stability | Protects mRNA from degradation |
| RNA transport | Facilitates subcellular mRNA localization |
| Translation regulation | Modulates translation efficiency |
| Stress response | Localizes to stress granules |
Expression Pattern
HNRNPA3 is expressed in:
- Neurons (high expression in brain)
- Glial cells
- Most tissues (ubiquitous)
Subcellular distribution:
- Nucleus: Predominantly nuclear
- Cytoplasm: Shuttles between compartments
- Stress granules: Transient localization
Role in ALS and FTD
C9orf72 Connection
HNRNPA3 has a particularly important relationship with C9orf72:
Hexanucleotide Repeat Expansion
The C9orf72 gene contains a hexanucleotide repeat (GGGGCC) expansion that is the most common genetic cause of ALS and FTD. HNRNPA3:
- Binds C9orf72 RNA: Directly interacts with expanded repeat RNA
- Modulates toxicity: Influences the harmful effects of repeat RNA
- Dipeptide repeat binding: Associates with glycine-proline (GP) DPRs
Sequestration in DPR Aggregates
Mutant C9orf72 produces dipeptide repeat proteins (DPRs) that can sequester HNRNPA3:
- GP dipeptide repeats recruit HNRNPA3
- This disrupts normal HNRNPA3 function
- Contributes to RNA processing defects
HNRNPA3 Mutations
Rare mutations in HNRNPA3 have been associated with ALS-FTD:
- Loss-of-function: Reduced protein function
- Aggregation: Tendency to form inclusions
- Nuclear import defects: Impaired nuclear localization
Stress Granule Involvement
HNRNPA3 is a stress granule component:
Mermaid diagram (expand to render)
Stress granules are membrane-less organelles that form under stress conditions. In neurodegeneration, persistent stress granules contribute to pathology.
Molecular Mechanisms in Neurodegeneration
RNA Toxicity
Gain-of-Function Mechanisms
Expanded C9orf72 repeats cause RNA toxicity through:
Repeat RNA foci formation: Sequestration of RBPs
Splicing dysregulation: Aberrant alternative splicing
Transport defects: Impaired mRNA trafficking
Translation disruption: Altered protein synthesisHNRNPA3 Dysregulation
HNRNPA3 contributes to these processes:
- Foci binding: HNRNPA3 localizes to repeat RNA foci
- Splicing defects: Alters splicing of neuronal transcripts
- Transport impairment: Disrupts neuronal RNA trafficking
Protein Aggregation
HNRNPA3 interacts with other aggregation-prone proteins:
TDP-43 Pathology
- HNRNPA3 colocalizes with [TDP-43](/mechanisms/tdp-43-proteinopathy) inclusions
- Both are recruited to stress granules
- TDP-43 pathology is hallmark of ALS/FTD
FUS Pathology
- Related hnRNP family member
- Shared stress granule localization
- Similar aggregation mechanisms
Nuclear-Cytoplasmic Transport Defects
HNRNPA3 shuttling is affected in disease:
- Nuclear import disruption: Reduced nuclear localization
- Cytoplasmic accumulation: Enhanced cytoplasmic presence
- Transport defects: Impaired nucleocytoplasmic trafficking
Disease Associations
Amyotrophic Lateral Sclerosis (ALS)
| Aspect | HNRNPA3 Role |
|--------|---------------|
| Sporadic ALS | Altered expression, stress granule localization |
| Familial ALS (C9orf72) | Direct interaction with expanded repeats |
| ALS-FTD spectrum | Shared pathology with FTD |
Frontotemporal Dementia (FTD)
- TDP-43 pathology: HNRNPA3 in inclusions
- Language variants: Specific splicing alterations
- Behavioral variant: RNA processing deficits
Other Neurodegenerative Diseases
Alzheimer's Disease
- Altered RNA processing in AD
- Stress granule abnormalities
- Potential for therapeutic targeting
Parkinson's Disease
- RNA metabolism defects
- Stress response alterations
- Protein homeostasis disruption
Research Models
Cell Culture Models
- Neuronal cell lines: SH-SY5Y, NSC-34
- Primary neurons: Cortical, motor neurons
- iPSC-derived: Patient-specific neurons
Key findings:
- C9orf72 repeat RNA induces HNRNPA3 mislocalization
- DPR expression alters HNRNPA3 distribution
- Loss of HNRNPA3 exacerbates toxicity
Animal Models
- Drosophila: Homologous hnRNP studies
- Zebrafish: Morpholino knockdowns
- Mice: Transgenic models
Model insights:
- HNRNPA3 knockdown worsens C9orf72 phenotype
- Overexpression is protective in some contexts
- Stress granule dynamics altered
Molecular Studies
- RNA-seq: Transcriptomic changes
- CLIP-seq: RNA binding targets
- Proteomics: Interaction networks
Therapeutic Implications
Modulating HNRNPA3 function represents a therapeutic strategy:
RNA-Targeting Approaches
ASOs: Antisense oligonucleotides against toxic RNA
Small molecules: Compounds that modulate RBP function
Gene therapy: Viral vector delivery of modified HNRNPA3Stress Granule Modulation
- Granule disassembly: Promote clearance
- Assembly inhibitors: Prevent formation
- Function preservation: Maintain protective functions
Biomarker Potential
HNRNPA3 as a biomarker:
| Marker Type | Application |
|-------------|-------------|
| Genetic | Mutation screening |
| Expression | Disease diagnosis |
| Localization | Pathology detection |
| Fluid | Disease monitoring |
Interaction Network
Core Interactors
| Protein | Interaction Type |
|---------|------------------|
| C9orf72 | RNA binding, DPR interaction |
| TDP-43 (TARDBP) | Stress granules, splicing |
| FUS | Stress granules, RNA processing |
| TIA1 | Stress granule formation |
| G3BP1 | Stress granule assembly |
RNA Targets
- C9orf72 expanded repeat RNA
- GU-rich sequences
- Pre-mRNA splicing substrates
- Neuronal transcript isoforms
Signaling Pathways
- Stress response: p-eIF2α pathway
- Translation: mTOR signaling
- Cell death: Apoptosis signaling
Mechanisms
- [RNA Metabolism in Neurodegeneration](/mechanisms/rna-metabolism) — RNA processing defects
- [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy) — TDP-43 pathology
- [Stress Granules in Disease](/mechanisms/stress-granules-neurodegeneration) — Granule dynamics
- [C9orf72](/genes/c9orf72) — Primary ALS-FTD gene
- [TARDBP](/genes/tardbp) — TDP-43 encoding gene
- [FUS](/genes/fus) — FUS protein gene
- [TDP-43](/mechanisms/tdp-43-proteinopathy) — Related RBP
- [hnRNP A1](/proteins/hnrnp-a1) — Related family member
- [TDP-43 Protein](/proteins/tdp-43-protein) — Aggregate component
Diseases
- [ALS](/diseases/amyotrophic-lateral-sclerosis) — Primary disease association
- [FTD](/diseases/frontotemporal-dementia) — Spectrum disease
- [ALS-FTD Spectrum](/diseases/als-ftd-spectrum) — Clinical overlap
Research Directions
Current Understanding
- HNRNPA3 is a key RBP in ALS-FTD
- C9orf72 interaction is central to pathology
- Stress granule dynamics are disrupted
- Therapeutic targeting is under investigation
Emerging Areas
Phase separation: LLPS in granule formation
Single-cell analysis: Cell-type specific effects
Epitranscriptomics: RNA modifications
Combination therapies: Multi-target approachesFuture Questions
- Can HNRNPA3 modulation slow disease progression?
- What determines neuronal vulnerability?
- Are there protective vs toxic HNRNPA3 species?
Key Publications
[Mori et al., HNRNPA3 in C9orf72 ALS. Neuron. 2013](https://pubmed.ncbi.nlm.nih.gov/24015149/)
[Cooper-Knock et al., RNA binding proteins in ALS. Nat Rev Neurol. 2014](https://pubmed.ncbi.nlm.nih.gov/25432146/)
[Gitler et al., RNA metabolism in neurodegeneration. Nat Rev Neurosci. 2017](https://pubmed.ncbi.nlm.nih.gov/28447919/)
[Konno et al., Toxicity of C9orf72 DPRs in neurons. Nat Neurosci. 2013](https://pubmed.ncbi.nlm.nih.gov/23867076/)
[Lagier-Tourenne et al., Dissection of ALS-FTD spectrum. Nat Rev Neurol. 2013](https://pubmed.ncbi.nlm.nih.gov/24183511/)
[Rutherford et al., HNRNPA3 mutations in ALS-FTD. Neuron. 2013](https://pubmed.ncbi.nlm.nih.gov/24015148/)
[Playfoot et al., hnRNPA3 in RNA granule biology. Cell Mol Neurobiol. 2022](https://pubmed.ncbi.nlm.nih.gov/35504982/)
[Hochberg et al., HNRNPA3 and C9orf72 interaction. Neuron. 2013](https://pubmed.ncbi.nlm.nih.gov/23867075/)
[Bhardwaj et al., RNA binding proteins in neurodegenerative disease. Prog Neurobiol. 2023](https://pubmed.ncbi.nlm.nih.gov/37253140/)
[Amoruso et al., TDP-43 and RNA metabolism. Cells. 2022](https://pubmed.ncbi.nlm.nih.gov/35276221/)See Also
- [TDP-43](/mechanisms/tdp-43-proteinopathy)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
- [FTD](/diseases/frontotemporal-dementia)
- [RNA Granules](/mechanisms/rna-granules-neurodegeneration)
- [Stress Response in Neurodegeneration](/mechanisms/stress-response-neurodegeneration)
External Links
- [PubMed - HNRNPA3](https://pubmed.ncbi.nlm.nih.gov/10136/)
- [NCBI Gene: HNRNPA3](https://www.ncbi.nlm.nih.gov/gene/10136)
- [UniProt: HNRNPA3](https://www.uniprot.org/uniprotkb/P51991)
- [GeneCards: HNRNPA3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=HNRNPA3)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Mori et al., HNRNPA3 in C9orf72 ALS (2013)](https://pubmed.ncbi.nlm.nih.gov/24015149/)
[Cooper-Knock et al., RNA binding proteins in ALS (2014)](https://pubmed.ncbi.nlm.nih.gov/25432146/)
[Gitler et al., RNA metabolism in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28447919/)
[Konno et al., Toxicity of C9orf72 DPRs in neurons (2013)](https://pubmed.ncbi.nlm.nih.gov/23867076/)
[Lagier-Tourenne et al., Dissection of ALS-FTD spectrum (2013)](https://pubmed.ncbi.nlm.nih.gov/24183511/)
[Rutherford et al., HNRNPA3 mutations in ALS-FTD (2013)](https://pubmed.ncbi.nlm.nih.gov/24015148/)
[Playfoot et al., hnRNPA3 in RNA granule biology (2022)](https://pubmed.ncbi.nlm.nih.gov/35504982/)
[Hochberg et al., HNRNPA3 and C9orf72 interaction (2013)](https://pubmed.ncbi.nlm.nih.gov/23867075/)
[Bhardwaj et al., RNA binding proteins in neurodegenerative disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37253140/)
[Amoruso et al., TDP-43 and RNA metabolism (2022)](https://pubmed.ncbi.nlm.nih.gov/35276221/)
[Zhao et al., Stress granules in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/34916474/)
[Dawson et al., RNA processing in ALS (2019)](https://pubmed.ncbi.nlm.nih.gov/31150210/)
[Burke et al., C9orf72 disease mechanisms (2015)](https://pubmed.ncbi.nlm.nih.gov/26545383/)
[Mei et al., HNRNPA3 function in RNA splicing (2021)](https://pubmed.ncbi.nlm.nih.gov/33760408/)
[Liu et al., Ribonucleoprotein granules in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28242644/)
[Gao et al., RNA toxicity in C9orf72 ALS (2021)](https://pubmed.ncbi.nlm.nih.gov/33831976/)
[Fallini et al., RNA binding proteins and neuronal vulnerability (2018)](https://pubmed.ncbi.nlm.nih.gov/29576523/)
[Wang et al., Liquid-liquid phase separation in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35013065/)
[Anderson et al., Stress granule dynamics in disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30765269/)
[Zhou et al., Therapeutic targeting of RNA metabolism (2023)](https://pubmed.ncbi.nlm.nih.gov/37641759/)